Navigation Links
Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study
Date:2/9/2009

women who had been using a topical microbicide or oral antiretrovirals as an HIV preventive measure when they acquired HIV infection.

A second large trial testing the safety and effectiveness of the 0.5% dose of PRO 2000 is currently underway. This trial is being sponsored by the United Kingdom's Medical Research Council (MRC) and conducted by the Microbicides Development Programme (MDP), an international partnership of researchers established to develop microbicides for the prevention of HIV transmission. Study MDP 301 is a multi-national, randomized, double-blind, placebo-controlled Phase III trial designed to examine the safety and effectiveness of PRO 2000 in preventing HIV infection in women. As in the HPTN 035 trial, all participants receive free condoms, risk-reduction counseling, and treatment for sexually transmitted infections. Approximately 9,400 women have been enrolled at study sites in South Africa, Tanzania, Uganda, and Zambia. The trial is expected to be completed during the summer of 2009.

Should PRO 2000 be shown conclusively to be safe and effective, Indevus intends to seek worldwide marketing approvals, and plans to work with government agencies and other organizations to help ensure affordable access to the product in resource-limited settings where the need is greatest.

According to statistics from UNAIDS and the U.S. Centers for Disease Control and Prevention, nearly half of the 33 million people living with HIV/AIDS worldwide are women. Most HIV infections in women are due to heterosexual intercourse. Moreover, women are twice as likely as their male partners to acquire HIV during sex, due in part to biological factors that make women more vulnerable. Although correct and consistent use of male condoms has been shown to prevent HIV infection, women often cannot negotiate condom use with their male partners. A safe and effective vaginal microbicide could offer a readily available app
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
2. Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000
3. Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
4. Indevus Pharmaceuticals Provides Update on PRO 2000 Program
5. Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
6. Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial
7. Indevus Announces Submission of New Drug Application
8. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
9. Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV
10. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
11. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Germany , August 28, 2014 ... available free of charge for people from 40 to 65 ... next two decades. Using a traffic light color scheme, the ... at risk. The new "CAIDE Dementia Risk App ... developed in collaboration with Karolinska Institutet in Stockholm ...
(Date:8/28/2014)... , Aug. 28, 2014 Synthetic ... novel anti-infective biologic and drug candidates targeting specific ... FUJIFILM Diosynth Biotechnologies UK Limited (Fujifilm), announced today ... of cGMP manufacturing of SYN-004, Synthetic Biologics, proprietary ... Clostridium difficile ( C. difficile ) infections. ...
(Date:8/28/2014)... -- Today is the official launch of a newly ... and pharmaceutical organizations that will work together to help ... medication. The Coalition will initially focus its efforts on ... nonmedical use vary, a 2013 study at one large ... college students reported nonmedical use of prescription stimulant medication ...
Breaking Medicine Technology:CAIDE Looks into the Future: New App from Merz Pharmaceuticals Assesses the Risk of Getting Dementia Within the Next 20 Years 2Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 2Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 3Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 4Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 5New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 2New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 3New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 4New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 5New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 6
... Inc. (Nasdaq: CRDC ) today announced that ... Proximal Anastomosis System during on- and off-pump coronary artery ... secure connection, or anastomosis, between a vein graft and ... during CABG procedures and was first shipped to Japan ...
... PHILADELPHIA, Jan. 26, 2012  The IP & Science ... Brazil,s Institute for Applied Economic Research (IPEA). This ... Policies for Innovation, Regulation and Infrastructure (DISET) branch ... of products, including generic pharmaceutical intelligence and tools ...
Cached Medicine Technology:Cardica Achieves Key Milestone With Over 25,000 PAS-Port® Proximal Anastomosis Systems Deployed Worldwide 2Thomson Reuters Helps Brazil's Institute for Applied Economic Research Identify New Generic Drug Opportunities 2
(Date:8/28/2014)... 2014 Canadian Linen and Uniform Service, ... America, today announced the launch of its new Customer ... with Canadian Linen even easier and more convenient for ... account information online and better communicate with the company. ... ability to:, , Access, download and ...
(Date:8/28/2014)... After more than two years of designing ... to announce the opening of Houston’s Mirror Mirror Beauty ... Mirror Mirror Beauty Boutique offers premium aesthetic services in ... of Richmond and Drexel near Highland Village, Mirror Mirror ... technology in a private, easy to access location. Patients ...
(Date:8/28/2014)... 28, 2014 Clarity PSO , ... re-certified as a federal Patient Safety Organization (PSO) for ... for Healthcare Research and Quality (AHRQ). Clarity PSO will ... and services following the true intentions of the Patient ... ”We are proud and eager to continue our journey ...
(Date:8/28/2014)... 2014 CMMI (Center for Medicare and Medicaid ... care to address patient needs. What does it all mean? ... (with more provider accountability) and reduce the cost of care. ... in the care of a patient get a single payment ... distribute it. If it sounds complicated, that's because it is. ...
(Date:8/28/2014)... 28, 2014 On September 10, the ... Isaacs, the chairperson, president and CEO of Aduro BioTech, ... the Mesothelioma Experts live broadcast. The interview will ... mesothelioma expert nurse practitioner, Mary Hesdorffer, APRN . ... Aduro BioTech’s experimental therapy for malignant pleural mesothelioma, known ...
Breaking Medicine News(10 mins):Health News:Canadian Linen and Uniform Service Launches New Customer Portal 2Health News:Canadian Linen and Uniform Service Launches New Customer Portal 3Health News:Mirror Mirror Beauty Boutique to Welcome Its First Patients 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Med-Certification.com Expects Industry "Hiccups" with New Models for Patient Care and Reimbursement 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 3
... 6 Align Technology, Inc. (Nasdaq: ALGN ) ... speak at two upcoming financial conferences. Both presentations, as noted ... section of Align Technology,s website at http://investor.aligntech.com . An ... three months. , Conference: Bank ...
... M. D. Anderson Clinical Services Outside of Houston PHOENIX, ... University of Texas M. D. Anderson Cancer Center announced ... here. The initiative joins Arizona,s leading provider of health care ... their families with an unprecedented level of cancer care in ...
... Africa, May 6 The healthcare industry ... vast inequalities in access to care. The ... 85.0% of the population, yet accounts for ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )Public-private partnerships offer an innovative ...
... and wife Ellen honored for generous contribution to New York University ... ... -- Dr. Jan Linhart, D.D.S. and his wife, Ellen Linhart, have ... Education Program at Dr. Linhart’s alma mater. In honor of this ...
... largest hospital ship charity were honored with a humanitarian award at a ... ... May 6, 2009 -- The founders of the world,s largest hospital ship ... London last night. , , , , ,The annual Variety ...
... innovation is L-Tox, for advanced liver support. L-Tox was formulated to ... , ... Anaheim, California (PRWEB) May 6, 2009 - ... a stop product use directive on May 1, 2009. All consumers ...
Cached Medicine News:Health News:Align Technology Executives to Present at Upcoming Financial Conferences 2Health News:Banner Health, M. D. Anderson Announce Cancer Care Facility for Arizona 2Health News:Banner Health, M. D. Anderson Announce Cancer Care Facility for Arizona 3Health News:South Africa not Gaining the Full Benefit of PPPs in the Healthcare Sector, Says Frost & Sullivan 2Health News:South Africa not Gaining the Full Benefit of PPPs in the Healthcare Sector, Says Frost & Sullivan 3Health News:Manhattan Dentist Inducted Into The Sir Harold Acton Society 2Health News:Mercy Ships Founders Receive Humanitarian of the Year Award From Variety Club 2Health News:Mercy Ships Founders Receive Humanitarian of the Year Award From Variety Club 3Health News:Mercy Ships Founders Receive Humanitarian of the Year Award From Variety Club 4Health News:Max Muscle Sports Nutrition Offers Support for Hydroxycut Recall 2Health News:Max Muscle Sports Nutrition Offers Support for Hydroxycut Recall 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: